Email UpdatesChildbirth, Breastfeeding and Infant Care: Methadone and Buprenorphine
Provides information for pregnant women about how taking methadone or buprenorphine may affect delivery, breastfeeding, and newborn infants.
Medication Considerations
Provide information or materials on the three medications approved by the Food and Drug Administration to treat opioid use disorder.
Pregnancy: Methadone and Buprenorphine
Provides information about treatment with methadone and buprenorphine for pregnant women.
Common Questions and Concerns About Medication Assisted Treatment (MAT): A Handout for Ambivalent Patients
Provides answers to common questions and concerns about MAT to help patients make informed decisions.
Buprenorphine/Naloxone Maintenance Treatment Information for Opioid Dependence
Provides general information about opioids, treatment of opioid addiction, and how family members can support those going through treatment.
Buprenorphine/Naloxone Maintenance Treatment Information for Patient
Provides an overview for patients about buprenorphine/naloxone maintenance treatment.
Common Questions and Concerns About Medication Assisted Treatment (MAT): A Handout for Family Members of a Person With Opioid Use Disorder (OUD)
Gives an overview of MAT for family members of a person with OUD.
Buprenorphine Treatment: Training for Multidisciplinary Addiction Professionals
Offers awareness training to disseminate information and enhance awareness among multidisciplinary (nonphysician) addiction professionals about buprenorphine treatment. Provides a broad overview of the medication, its effects, and the role of nonphysician practitioners.
ASAM National Practice Guideline App
Gives healthcare providers instant access to current opioid-related guidelines in a clear, concise format.
Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
Provides information for treating pregnant and parenting women with OUD, as well as their infants.
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series 43
Describes the nature and dimensions of OUDs and their treatment, consensus panel recommendations and evidence-based best practices for opioid treatment programs (OTPs), related co-occurring disorders and their treatment, and ethical considerations that arise in most OTPs.